Motilal Oswal recommended Neutral rating on GSK Pharma with a target price of Rs 1420 in its research report dated November 12, 2022.
Subscribe To Our Free Newsletter |
Motilal Oswal recommended Neutral rating on GSK Pharma with a target price of Rs 1420 in its research report dated November 12, 2022.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!